CCR2 and myeloid sarcoma: Notably, in the early MS group, increased cell frequencies were detected in the clusters that were ADRPloCCR2+T-betlo (cluster 2), while ADRP+CCR2+T-bet+ cells (cluster 3) were less abundant compared with healthy controls (Fig. 5a–c).